MD

Pediatrix Medical Group, Inc. - 10-K Summary (Fiscal Year Ended Dec 31, 1999)

Business Context and Reporting Period

This report covers the fiscal year ended December 31, 1999, for Pediatrix Medical Group, Inc. (PMG), the nation's leading provider of physician services to hospital-based Neonatal Intensive Care Units (NICUs) and Perinatal practices. As of year-end, the Company operated in 25 states and Puerto Rico, employing or contracting with 434 physicians. The Company's strategy focuses on growth through acquisitions and the development of regional networks to strengthen relationships with managed care organizations.

Key Financial Metrics

Liquidity Note: The Company maintained a working capital deficit of $16.4 million, primarily due to the classification of its $48.4 million Line of Credit as a current liability. Excluding this line of credit, working capital increased by approximately $17.1 million.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 22.4% to $227.0 million, driven by 11 acquisitions adding 23 NICUs, one PICU, and four perinatal practices. However, same-unit revenue decreased 5.3% due to lower patient acuity levels.
• Profitability Decline: Net income decreased 14.0% to $25.0 million. Operating income fell 8.1% to $45.0 million. The operating margin compressed from 26.4% to 19.8% due to increased operating expenses.
• Expense Increases: Salaries and benefits rose 30.9% ($35.2 million) due to new physician hires and support staff. Supplies and other operating expenses increased 49.8% ($7.0 million), partly due to legal fees related to government investigations. Depreciation and amortization increased 39.1% due to goodwill amortization from acquisitions.
• Debt Expansion: Long-term debt increased significantly to $50.7 million from $10.4 million as the Company utilized its credit facility to fund acquisitions.

Outlook, Risks, and Contingencies

Guidance and Outlook: Management anticipates that funds from operations and existing financing will meet working capital requirements for the next twelve months, provided they can secure financing similar to their current Line of Credit, which matures on September 30, 2000. The Company continues to pursue acquisitions and regional network development.

Material Risks and Contingencies:

• Securities Litigation: The Company is defending against consolidated federal securities class actions alleging false statements regarding accounting practices and revenue recognition. Plaintiffs seek undetermined damages.
• Billing Investigations: Ongoing investigations by state authorities in Arizona, Colorado, and Florida regarding billing practices. The Company is cooperating but cannot predict the outcome or financial impact.
• Regulatory Environment: Significant reliance on government programs (21% of revenue). Risks include potential reductions in Medicaid reimbursement, changes in managed care contracts, and challenges regarding the "corporate practice of medicine" and anti-kickback statutes.
• Accounting Changes: Effective Jan 1, 1999, the Company began expensing certain acquisition-related costs rather than capitalizing them, following SEC guidance.

Investor Verification Checklist

• Verify the status and potential financial exposure of the federal securities class action lawsuits and state billing investigations.
• Confirm the Company's ability to refinance or extend its $75 million Line of Credit maturing in September 2000.
• Monitor the impact of the shift in payor mix (Managed Care increased to 45% of revenue) on future reimbursement rates and margins.
• Assess the sustainability of same-unit revenue growth given the reported 5.3% decline in 1999.
• Review the Company's compliance with state laws regarding the corporate practice of medicine and fee-splitting arrangements with PA Contractors.